Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Marco Donia(University of Copenhagen), Inge Marie Svane(Copenhagen University Hospital), Paolo Fagone(University of Catania), Mads Hald Andersen(Copenhagen University Hospital), Rikke Andersen(Herlev Hospital), Julie Westerlin Kjeldsen(Copenhagen University Hospital), Shamaila Munir Ahmad(Herlev Hospital), Ferdinando Nicoletti(University of Catania), Per thor Straten(Herlev Hospital)
Cited by 124
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495